At 24 hours, participants receiving dexamethasone were not more likely than those Oct 14, 2023 · Methods: Four hundred seventeen patients with RRMM who had previously received at least two regimens were randomly assigned (2:1) to receive aponermin, thalidomide, and dexamethasone or placebo, thalidomide, and dexamethasone
In the placebo group, 3 patients withdrew due to respiratory failure (n = 1), pulmonary edema (n = 1)
Overall PES occurred in 48
A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical
These
In this double-blind, placebo-controlled trial, newly diagnosed patients without an indication for high dose immunosuppressive therapy were randomised to once-daily
Summarize the mechanism of action of dexamethasone
Methods: In this double-blind, placebo-controlled trial, newly diagnosed patients without an indication for high dose immunosuppressive therapy were randomised to once-daily
75 mg; 1 mg; 1
2 mg/kg dexamethasone or a saline placebo as an intravenous bolus within 5 minutes
The primary objective of this prospective, randomized, double-blind, placebo-controlled study was to compare the effect of dexamethasone and placebo on CRF
Patients received either dexamethasone or identical placebo for 6 weeks as follows: intravenous administration of 0
Administration of dexamethasone changed the dynamics of the cytokine response (Fig
The dexamethasone (n=50) and placebo (n=51) groups were similar in age, severity of illness and etiological agent
Design : Double blind, randomised, placebo controlled clinical trial
The patients given dexamethasone had a significantly shorter hospital stay than those receiving placebo
Spearman ρ correlation coefficients were used to evaluate associations of cluster scores at baseline, day 8, and day 15 after treatment of dexamethasone
In the acetic acid/taping group, significance for morning stiffness and residual stiffness was maintained, and this reflected a significant
Event rates with the combination therapy were very low, between 2% and 5% for both early and late outcomes
RESULTS--Baseline characteristics of the two treatment groups were similar
Objectives: In this randomized-controlled study, we investigated the effects of combined administration of pregabalin and dexamethasone on postoperative pain and analgesic requirements, and functional outcome in patients who underwent lumbar spinal surgery
Block duration was similar between systemic dexamethasone and placebo (mean difference 36 min; 95% CI, –30 to 103)
Methods: A double blinded, randomised, placebo controlled trial of 31 patients with medial calcaneal origin plantar fasciitis recruited from three sports medicine clinics
Patients were randomized to receive placebo or dexamethasone 0